Neuvoa-antavan komitean muodostavat eri tutkimusalojen asiantuntijat, jotka yhdessä tekevät valtavan työn vuosittaisten tutkimusapurahahakemusten käsittelyssä. Asiantuntijaryhmä käy läpi kaikki saapuvat hakemukset ja arvottaa ne säännöstön mukaisesti. Neuvoa-antava komitea suosittelee säätiön hallitukselle tutkimushankkeita, jotka heidän mielestään ovat soveltuvimpia apurahojen saajiksi.
Neuvoa-antavaan komiteaan kuuluvat seuraavat henkilöt:
Professor John Wilding
John Wilding leads Clinical Research into Obesity, Diabetes and Endocrinology at the University of Liverpool. He is an Associate Editor of Diabetic Medicine, and chairs the National Clinical Research Network Metabolic and Endocrine Speciality Group.
Dr. Ola Hansson
Ola Hansson has a basic education in biology and received his PhD in experimental diabetes research in 2005. He is since 2013 associate professor of functional genomics, currently heading the research unit Genomics, Diabetes and Endocrinology at Lund university, Sweden.
Professor Paul Johnson
Paul is Professor of Paediatric Surgery at the University of Oxford and Director of the Oxford Human Islet Isolation and Clinical Islet Transplant Programs. He is also Clinical Lead for the NHS Thames Valleyand Wessex Surgery in Children Operational Delivery Network (ODN) and Academic Training Program Director for the Oxford University Clinical Academic Graduate School (OUCAGS).
Professor Patrik Rorsman
Patrik Rorsman is Professor of Diabetic Medicine at the University of Oxford. He has worked extensively on the physiology of the pancreatic islets. His research focuses on the physiological regulation of insulin, glucagon and somatostatin secretion, how these processes become disrupted in type-1 and typoe-2 diabetes and whether they can be targeted by pharmacological interventions.
Dr Nils Wierup
Nils Wierup is professor in cell biology at Lund University Diabetes Centre. He is vice coordinator of LUDC and is head of the research group Neuroendocrine cell biology. His research is focused on islet biology and gastro-intestinal endocrinology and how islet and enteroendocrine cells are affected in Type 2 diabetes, with the aim of identifying targetable disease mechanisms.
Dr. Hanne Scholz
Dr. Hanne Scholz is a main principle investigator at the Transplant Unit, Oslo University Hospital and at the Hybrid Technology Hub at the University in Oslo.
Dr James Cantley
James Cantley is a Reader at the University of Dundee, where he holds a Senior Research Fellowship from the Steve Morgan Foundation Type 1 Diabetes Grand Challenge. His research is focused on investigating pancreatic beta cell function and insulin secretion in the context of type 1 and type 2 diabetes, working at the interface of biochemistry, cell biology and metabolic physiology.
Dr Janaka Karalliedde
Dr Karalliedde is a Clinical Reader in Diabetes and Cardiovascular Disease in the School of Cardiovascular Medicine & Sciences at King’s College London and Consultant Physician in Diabetes and Endocrinology and Internal Medicine at Guy’s and St Thomas Hospital London. He graduated with a distinction in medicine from the University of London.
Professor Duan Chen
Duan Chen (MD, PhD) is Principal Investigator of Research Group of Experimental Surgery and Pharmacology at Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU). He graduated from University of Lund, Sweden and is a Professor of Medicine (Experimental Surgery) at NTNU. He is member of the Norwegian Academy of Technological Sciences and the Royal Norwegian Academy of Science.
Dr Jakob Grunnet Knudsen
Jakob G Knudsen is an assistant professor at the University of Copenhagen. His research focuses on basic alpha cell function and glucagon biology and how these processes become disrupted with metabolic disease and contribute to the development of diabetes.